|
1
|
Runnebaum IB and Stickeler E:
Epidemiological and molecular aspects of ovarian cancer risk. J
Cancer Res Clin Oncol. 127:73–79. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin HW, Tu YY, Lin SY, Su WJ, Lin WL, Lin
WZ, Wu SC and Lai YL: Risk of ovarian cancer in women with pelvic
inflammatory disease: a population-based study. Lancet Oncol.
12:900–904. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rocconi RP, Numnum TM, Stoff-Khalili M,
Makhija S, Alvarez RD and Curiel DT: Targeted gene therapy for
ovarian cancer. Curr Gene Ther. 5:643–653. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yap TA, Carden CP and Kaye SB: Beyond
chemotherapy: targeted therapies in ovarian cancer. Nat Rev Cancer.
9:167–181. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kimball KJ, Numnum TM, Rocconi RP and
Alvarez RD: Gene therapy for ovarian cancer. Curr Oncol Rep.
8:441–447. 2006. View Article : Google Scholar
|
|
6
|
Rainov NG: A phase III clinical evaluation
of herpes simplex virus type 1 thymidine kinase and ganciclovir
gene therapy as an adjuvant to surgical resection and radiation in
adults with previously untreated glioblastoma multiforme. Hum Gene
Ther. 11:2389–2401. 2000. View Article : Google Scholar
|
|
7
|
Shand N, Weber F, Mariani L, Bernstein M,
Gianella-Borradori A, Long Z, Sorensen AG and Barbier N: A phase
1–2 clinical trial of gene therapy for recurrent glioblastoma
multiforme by tumor transduction with the herpes simplex thymidine
kinase gene followed by ganciclovir. GLI328 European-Canadian Study
Group. Hum Gene Ther. 10:2325–2335. 1999.
|
|
8
|
Aoi A, Watanabe Y, Mori S, Takahashi M,
Vassaux G and Kodama T: Herpes simplex virus thymidine
kinase-mediated suicide gene therapy using nano/microbubbles and
ultrasound. Ultrasound Med Biol. 34:425–434. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Z, Liang K, Liu J, Xie M, Wang X, Lü
Q, Zhang J and Fang L: Enhancement of survivin gene downregulation
and cell apoptosis by a novel combination: liposome microbubbles
and ultrasound exposure. Med Oncol. 26:491–500. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaur T, Slavcev RA and Wettig SD:
Addressing the challenge: current and future directions in ovarian
cancer therapy. Curr Gene Ther. 9:434–458. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Piscaglia F and Bolondi L: Italian Society
for Ultrasound in Medicine and Biology (SIUMB) Study Group on
Ultrasound Contrast Agents: The safety of Sonovue in abdominal
applications: retrospective analysis of 23188 investigations.
Ultrasound Med Biol. 32:1369–1375. 2006. View Article : Google Scholar
|
|
12
|
Chen S, Shimoda M, Wang MY, Ding J,
Noguchi H, Matsumoto S and Grayburn PA: Regeneration of pancreatic
islets in vivo by ultrasound-targeted gene therapy. Gene Ther.
17:1411–1420. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujii H, Sun Z, Li SH, Wu J, Fazel S,
Weisel RD, Rakowski H, Lindner J and Li RK: Ultrasound-targeted
gene delivery induces angiogenesis after a myocardial infarction in
mice. JACC Cardiovasc Imaging. 2:869–879. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Delalande A, Bureau MF, Midoux P, Bouakaz
A and Pichon C: Ultrasound-assisted microbubbles gene transfer in
tendons for gene therapy. Ultrasonics. 50:269–272. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang ZX, Wang ZG, Ran HT, Ren JL, Zhang Y,
Li Q, Zhu YF and Ao M: The treatment of liver fibrosis induced by
hepatocyte growth factor-directed, ultrasound-targeted microbubble
destruction in rats. Clin Imaging. 33:454–61. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou S, Li S, Liu Z, Tang Y, Wang Z, Gong
J and Liu C: Ultrasound-targeted microbubble destruction mediated
herpes simplex virus-thymidine kinase gene treats hepatoma in mice.
J Exp Clin Cancer Res. 29:1702010. View Article : Google Scholar
|
|
17
|
Khaider NG, Lane D, Matte I, Rancourt C
and Piché A: Targeted ovarian cancer treatment: the TRAILs of
resistance. Am J Cancer Res. 2:75–92. 2012.PubMed/NCBI
|
|
18
|
Weberpals JI, Koti M and Squire JA:
Targeting genetic and epigenetic alterations in the treatment of
serous ovarian cancer. Cancer Genet. 204:525–535. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Z, Xie M, Wang X, Lv Q and Ding S:
Effects of lipid shell microbubble on ultrasound mediated EGFP gene
delivery to transplanted tumors: initial experience. Chin-Ger J
Clin Oncol. 7:424–428. 2008. View Article : Google Scholar
|
|
20
|
Liu P, Gao YH, Tan KB, Liu Z and Zuo S:
Grey scale enhancement of rabbit liver and kidney by intravenous
injection of a new lipid-coated ultrasound contrast agent. World J
Gastroenterol. 10:2369–2372. 2004.PubMed/NCBI
|
|
21
|
Carson AR, McTiernan CF, Lavery L, Hodnick
A, Grata M, Leng X, Wang J, Chen X, Modzelewski RA and Villanueva
FS: Gene therapy of carcinoma using ultrasound-targeted microbubble
destruction. Ultrasound Med Biol. 37:393–402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meijering BD, Juffermans LJ, van Wamel A,
Henning RH, Zuhorn IS, Emmer M, Versteilen AM, Paulus WJ, van Gilst
WH, Kooiman K, de Jong N, Musters RJ, Deelman LE and Kamp O:
Ultrasound and microbubble-targeted delivery of macromolecules is
regulated by induction of endocytosis and pore formation. Circ Res.
104:679–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Canine BF and Hatefi A: HSV-TK/GCV
cancer suicide gene therapy by a designed recombinant
multifunctional vector. Nanomedicine. 7:193–200. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nicholas TW, Read SB, Burrows FJ and Kruse
CA: Suicide gene therapy with Herpes simplex virus thymidine kinase
and ganciclovir is enhanced with connexins to improve gap junctions
and bystander effects. Histol Histopathol. 18:495–507.
2003.PubMed/NCBI
|
|
25
|
Mesnil M and Yamasaki H: Bystander effect
in herpes simplex virus-thymidine kinase/ganciclovir cancer gene
therapy: role of gap-junctional intercellular communication. Cancer
Res. 60:3989–3999. 2000.
|
